In postmenopausal women with type 2 diabetes, oral hormone replacement therapy (HRT) may increase the risk of CV events.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback